ZYTIGA
Glenmark Pharma gets USFDA nod for prostate cancer treatment drugShares of Glenmark Pharma were trading 0.15 per cent higher at Rs 286.00 apiece on the BSE.17 Oct, 2019, 03.41 PM IST
Sun Pharma rises with R&D and bets on specialty drugsSun Pharma- India's largest drug maker - is vying for its share in the US$9 billion market through a drug, Ilumya, that treats moderate-to-...05 Jun, 2018, 12.55 PM IST
Load More